Following acute occlusion of a coronary artery causing myocardial ischemia and
implementing first-line treatment involving rapid reperfusion, a dynamic and balanced …

Purpose Despite modern reperfusion and pharmacologic therapies, myocardial infarction
(MI) remains a leading cause of morbidity and mortality worldwide. Therefore, the …

Myocardial infarction necessitates new therapeutic interventions, since it still results in high
morbidity and mortality worldwide. Reperfusion therapy itself results in (acceleration of) …

Despite recent scientific and technological advances, myocardial infarction (MI) still
represents a major global health problem, leading to high morbidity and mortality worldwide …

One of the major therapeutic challenges in the arena of interventional cardiology is to design
strategies aimed at reducing myocardial tissue damage after myocardial infarction. In …

Although a decline in the all-cause and cardiac mortality rates following myocardial
infarction (MI) during the past 3 decades has been reported, MI is a major cause of death …

Early and prompt reperfusion therapy has markedly improved the survival rates among
patients enduring myocardial infarction (MI). Nonetheless, the resulting adverse remodeling …

New therapies are required to reduce myocardial infarct (MI) size and prevent the onset of
heart failure in patients presenting with acute myocardial infarction (AMI), one of the leading …

Growing evidence indicates that overactivation and prolongation of the inflammatory
response after acute myocardial infarction (AMI) result in worse left ventricular remodelling …

Myocardial infarction (MI) is one of the major contributors to worldwide morbidity and
mortality. It is atherosclerosis' most dreadful complication and occurs after the supply of …